Maxipime - 0409-0218-01 - (CEFEPIME HYDROCHLORIDE)

Alphabetical Index


Drug Information of Maxipime

Product NDC: 0409-0218
Proprietary Name: Maxipime
Non Proprietary Name: CEFEPIME HYDROCHLORIDE
Active Ingredient(s): 2    g/1 & nbsp;   CEFEPIME HYDROCHLORIDE
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Maxipime

Product NDC: 0409-0218
Labeler Name: Hospira, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA050679
Marketing Category: NDA
Start Marketing Date: 20121227

Package Information of Maxipime

Package NDC: 0409-0218-01
Package Description: 25 VIAL in 1 CARTON (0409-0218-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL

NDC Information of Maxipime

NDC Code 0409-0218-01
Proprietary Name Maxipime
Package Description 25 VIAL in 1 CARTON (0409-0218-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Product NDC 0409-0218
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name CEFEPIME HYDROCHLORIDE
Dosage Form Name INJECTION, POWDER, FOR SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20121227
Marketing Category Name NDA
Labeler Name Hospira, Inc.
Substance Name CEFEPIME HYDROCHLORIDE
Strength Number 2
Strength Unit g/1
Pharmaceutical Classes Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient]

Complete Information of Maxipime


General Information